Sublime

If you own $NBIS or $CORZ or $IREN (or in my case all 3) - you need to be full, loaded to the gills in $DGHI. The things we want/hope/expect those 3 names to be doing… $DGHI is doing/soon to be sharing I suspect. We have to connect the dots. They’re there. The only thing better than making $ is doing it w/ friends… ___... See more

Biotech Stock Catalyst Watchlist Q1 2023 ~55+ Catalysts remaining this qtr: $FDMT Phase 1/2 $CLDX Phase 1b $CYTK PDUFA $RETA PDUFA $IMGN Phase 3 $SNY PDUFA $REGN PDUFA $MGNX Phase 1 $ACAD PDUFA__... See more

@AtomicCorp $GLO $GLATF one of my favorite investments. Can't wait to see them embarrass the rest of the sector by ACTUALLY producing.

TechBio/AIDD is in a crucible moment. There's a MAJOR bottleneck at Series A/B. Biotech firms no longer underwrite platforms while "techbio" VCs are leaning out on tx risk. We're seeing great companies passed up or diluted. Lots of oppy for investors willing to step into the gap!

I believe that 2024 will be the year when the biotech sector finally reaches its lowest point after being beaten down the past few years -- here are my top biotech picks for this year 👇

Excited to feature 23 rising stars in #biotech investing and creation. What is biotech #VC and how does one get involved? What makes a promising investment? Also—the inner workings of a deal & advice for biotechs pitching in ‘23 #biomarker https://t.co/MAvpvWaCAQ

Why biotech will boom and biotech stocks depressed as they now are are the best buy in the stock market right now.